2123 The Effect of GLP-1RAs on Systemic Inflammation The ability of GLP-1RAs to reduce systemic inflammation (with decreases in hs-C-reactive protein, TNF-, interleukin-6 and interleukin IL-1) has been demonstrated in animal studies, studies on isolated human tissues and RCTs
No confirmed DSIP receptor Without an established receptor and a reproducible exposure-response relationship, statements that DSIP precisely resets sleep or directly increases deep sleep are not supported
Sleep apnea The issue An estimated 30 million people in the United States suffer from obstructive sleep apnea, in which breathing repeatedly stops and starts during sleep
2016/679, which entered into force on May 25, 2018 and is applicable personal data that we process in relation to our presence in the EU, the offering of products or services to individuals in the EU or the monitoring of the behavior of individuals in the EU, we have also a legal responsibility to report personal data breaches to the competent supervisory authority
Semaglutide is changing the landscape of obesity - and alternatives are on the way
NovakovicMRoutAKingsleyTKirchoffRSinghAVermaVet alRole of gut microbiota in cardiovascular diseases
